Article: Communicating The Value Of Next Generation Therapies
This piece originally appeared in the October 2019 edition of O’Dwyers Magazine. Communicating the value of one’s products to a variety of stakeholders (patients, payers, providers, policymakers, etc.) is nothing new. Biopharmaceutical companies have been doing this for decades through a variety of channels. However, the obligation to communicate more openly and explicitly has grown substantially. Recent […]
